Global Bentonite Market Growth, Market Insights and Forecast to 2025
“The Global Acne Treatment Market was valued around US$ 4,523.7 Mn in 2018 and burgeoning at significant CAGR over the forecast years 2019-2025 owing to increase in the prevalence of acne cases coupled with surge in R&D for the development of newer drugs”
The global acne treatment market accounted for US$ 4,523.7 Mn in 2018 and expected to burgeon at significant growth rate over the forecast years owing to surge in incidence of acne across the globe. For instance, according to a research study 2015, approximately 633 Mn people affected with acne across the globe. Moreover, rise in adoption of minimally 0nvasive acne treatment procedures, change in lifestyle, increase in prevalence of PCOD/PCOS and hirsutism, surge in R&D for the development of newer drugs, increase in awareness about the acne treatment procedures, and rise in disposable income are estimated to boost the market over the forecast years. However, stringent regulations for the product approval, lack of reimbursement policies, adoption of alternative treatment procedures, and adverse effects associated with the drugs are hamper the acne treatment market over the forecast timeframe
Global acne treatment market segmented on the basis of product type, acne type, route of administration, distribution channel, and region
For Request Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17306
Retinoids Dominate the Global Acne Treatment Market
Based on the product type, global acne treatment market segmented into retinoids, antibiotics, hormonal drugs, anti-inflammatory drugs, combination drugs, chemical peels, radiofrequency devices, laser devices, and others. Among all the products, retinoids hold the largest share in 2018 and the same trend is expected over the forecast years owing to rise in adoption of retinoids as first-line drugs and better efficacy with retinoids compared with other drugs. Moreover, rise in R&D for the development of OTC products also surge the segment revenue over the forecast years. For instance, in September 2019, AcneFree, a L'Oréal brand launched AF Adapalene Gel, an over-the-counter, once daily topical retinoid treatment for acne-prone skin.
North America Leads the Global Acne Therapeutics market
PBI’s global Acne Therapeutics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to increase in the acne cases in USA and Canada and rise in preference for the aesthetic appeal in teenage and young people. Moreover, rise in R&D for the launch of newer therapeutics by the market players, presence of huge number of market players, and grow in disposable income are bolster the market revenue over the future years. Europe acne treatment market projected to exhibit significant growth and creates lucrative opportunities over the forecast year due to increase in demand for minimally invasive cosmetic procedures, increase in adoption of acne treatment in Germany, France, and UK, and high awareness about the acne therapeutics in the region
Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players
Global acne treatment market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, in October 2019, Galderma received FDA approval for the Trifarotene (Aklief) topical retinoid 0.005% for the treatment of acne vulgaris in patients 9 years of age and older.
Key player’s profiles in the report are Johnson & Johnson, Allergan plc, Galderma S.A., Guthy-Renker, Stiefel Laboratories, Valeant Pharmaceutical International, Inc., Cipher Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, and Acne Free.
Precision Business Insights (PBI) in its report titled “Global Acne Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Detailed Segmentation
By Product Type
- Retinoids
- Antibiotics
- Hormonal Drugs
- Anti-inflammatory Drugs
- Combination Drugs
- Chemical Peels
- Radiofrequency Devices
- Laser Devices
- Others
By Acne Type
- Comedonal
- Inflammatory
- Cystic
- Postsurgical/wound
By Route of Administration
- Oral
- Topical
- Injectable
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
About Us
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Contact Us
Kemp House,
152 – 160 City Road,
London EC1V 2N0058
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553